G
Gordon Ruthel
Researcher at United States Army Medical Research Institute of Infectious Diseases
Publications - 24
Citations - 2869
Gordon Ruthel is an academic researcher from United States Army Medical Research Institute of Infectious Diseases. The author has contributed to research in topics: Ebola virus & Dendritic cell. The author has an hindex of 19, co-authored 24 publications receiving 2636 citations.
Papers
More filters
Journal ArticleDOI
Development of High-Content Imaging Assays for Lethal Viral Pathogens:
Rekha G. Panchal,Krishna P. Kota,Kevin B. Spurgers,Gordon Ruthel,Julie P. Tran,Robert C. “Dutch” Boltz,Sina Bavari +6 more
TL;DR: The authors demonstrate the benefits related to the statistical analyses of single-cell data to account for heterogeneity in the subcellular localization and whole-cell integrated intensity of the viral antigen staining pattern and show that image-based methods represent powerful screening tools for identifying antiviral compounds for highly pathogenic viruses.
Journal ArticleDOI
NKp30-dependent cytolysis of filovirus-infected human dendritic cells
Claudette L. Fuller,Gordon Ruthel,Kelly L. Warfield,Dana L. Swenson,Catharine M. Bosio,M. Javad Aman,Sina Bavari +6 more
TL;DR: This work reports that unlike authentic or inactivated Ebola and Marburg, filovirus‐derived virus‐like particles directly activated human natural killer cells in vitro, evidenced by pro‐inflammatory cytokine production and enhanced cytolysis of permissive target cells.
Journal ArticleDOI
Involvement of Vacuolar Protein Sorting Pathway in Ebola Virus Release Independent of TSG101 Interaction
Lynn S. Silvestri,Gordon Ruthel,George Kallstrom,Kelly L. Warfield,Dana L. Swenson,Timothy Nelle,Patrick L. Iversen,Sina Bavari,M. Javad Aman +8 more
TL;DR: Data show that EBOV can use vps proteins independently of TSG101 for budding and reveal VPS4 as a potential target for filovirus therapeutics.
Journal ArticleDOI
Gaining ground: assays for therapeutics against botulinum neurotoxin
TL;DR: This review examines the relevant and available in vitro cell-based assays and in vivo assays for drug discovery and development, especially with regard to the potential for medium- to high-throughput automation and its use in identifying physiologically relevant inhibitors.
Journal ArticleDOI
Reduced Expression of CD45 Protein-tyrosine Phosphatase Provides Protection against Anthrax Pathogenesis
Rekha G. Panchal,Ricky L. Ulrich,Steven B. Bradfute,Douglas Lane,Gordon Ruthel,Tara Kenny,Patrick L. Iversen,Arthur O. Anderson,Rick Gussio,William C. Raschke,Sina Bavari +10 more
TL;DR: This is the first report demonstrating that reduced levels of host phosphatase CD45 modulate anthrax pathogenesis, and Mechanism-based studies suggest that the protection provided by reduced CD45 levels results from regulated immune cell homeostasis that may diminish the impact of apoptosis during the infection.